VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ARWR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ARWRArrowhead Pharmaceuticals, Inc.
$83.99$11.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksARWRQuarterly Financials

Arrowhead Pharmaceuticals, Inc. (ARWR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Arrowhead Pharmaceuticals, Inc. (ARWR) quarterly income statement — complete revenue, gross profit & net income history

ARWR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue73.74M264.03M256.47M27.77M542.71M2.5M0003.55M16.1M15.82M146.27M62.55M31.57M32.41M151.81M27.44M38.28M45.89M
Revenue Growth %-86.41%10461.32%----29.6%-100%-100%-100%-94.32%-49.02%-51.18%-3.65%127.95%-17.52%-29.37%362.67%28.8%401.56%67.63%
Cost of Goods Sold6.37M000005.03M4.78M4.53M4.26M3.86M3.27M2.67M2.69M2.66M2.6M2.58M2.57M00
COGS % of Revenue8.64%--------120.05%23.97%20.7%1.83%4.3%8.42%8.03%1.7%9.38%--
Gross Profit67.37M264.03M256.47M27.77M542.71M2.5M-5.03M-4.78M-4.53M-712K12.24M12.55M143.6M59.86M28.91M29.81M149.22M24.87M00
Gross Margin %91.36%100%100%100%100%100%----20.05%76.03%79.3%98.17%95.7%91.58%91.97%98.3%90.62%--
Gross Profit Growth %-87.59%10461.32%5203.92%680.66%12093.57%451.12%-141.06%-138.1%-103.15%-101.19%-57.68%-57.9%-3.77%140.72%------
Operating Expenses208.63M223.22M212.37M193.32M161.51M163.91M157.18M171.36M121.67M135.83M120.57M115.25M95.43M101.99M112.75M102.72M107.67M88.19M100.66M75.76M
OpEx % of Revenue282.94%84.54%82.8%696.21%29.76%6556.48%---3825.2%749.01%728.3%65.25%163.07%357.07%316.91%70.92%321.39%262.95%165.08%
Selling, General & Admin41.24M45.52M37.18M30.44M27.89M26.4M25.79M23.2M24.64M23.19M24.17M23.37M22.82M20.58M31.62M32.74M33.86M24.59M37.39M17.86M
SG&A % of Revenue55.93%17.24%14.5%109.64%5.14%1056.04%---653.14%150.13%147.66%15.6%32.91%100.16%101.01%22.31%89.62%97.66%38.91%
Research & Development167.38M177.2M174.69M162.37M133.1M137M131.39M148.16M97.02M112.64M96.4M91.89M72.62M81.41M81.12M69.98M73.8M63.59M63.28M57.9M
R&D % of Revenue227%67.11%68.11%584.75%24.53%5480.08%---3172.06%598.88%580.64%49.65%130.16%256.92%215.91%48.62%231.77%165.29%126.17%
Other Operating Expenses0504K503K505K511K509K00000000000000
Operating Income-141.26M40.81M44.11M-165.55M381.2M-161.41M-162.2M-176.14M-126.19M-136.54M-108.33M-102.7M48.16M-42.13M-83.83M-72.91M41.55M-63.32M-64.88M-31.87M
Operating Margin %-191.57%15.46%17.2%-596.21%70.24%-6456.48%----3845.25%-672.98%-648.99%32.93%-67.36%-265.49%-224.94%27.37%-230.77%-169.48%-69.44%
Operating Income Growth %-137.06%125.28%127.19%6.01%402.08%-18.21%-49.73%-71.51%-362%-224.07%-29.23%-40.86%15.91%33.46%-29.2%-128.78%247.18%-163.25%-29.46%-99.85%
EBITDA-134.89M47.2M50.49M-159.33M387.29M-156.18M-157.18M-171.36M-121.67M-132.28M-104.47M-99.43M50.83M-39.45M-81.17M-70.31M44.15M-60.75M-62.38M-29.87M
EBITDA Margin %-182.94%17.88%19.69%-573.8%71.36%-6247.08%----3725.2%-649.01%-628.29%34.75%-63.07%-257.07%-216.94%29.08%-221.39%-162.94%-65.09%
EBITDA Growth %-134.83%130.22%132.12%7.02%418.32%-18.06%-50.45%-72.35%-339.34%-235.36%-28.71%-41.4%15.15%35.07%-30.12%-135.4%267.77%-173.57%-29.03%-107.29%
D&A (Non-Cash Add-back)6.37M6.39M6.39M6.22M6.08M5.24M5.03M4.78M4.53M4.26M3.86M3.28M2.67M2.69M2.66M2.59M2.59M2.57M2.5M2M
EBIT-141.26M50.78M57.81M-154.71M391.25M-153.47M-158.15M-168.88M-119.75M-133.32M-103.73M-98.22M52.73M-38.95M-83.83M-72.05M44.37M-63.32M-64.88M-31.87M
Net Interest Income-6.98M-12.81M-12.64M-13.36M-12.02M-14.04M-7.48M1.4M-994K-2.56M-1.38M-986K-497K-167K1.58M1.24M1.05M1.16M1.15M1.28M
Interest Income16.87M9.69M9.05M11.02M9.62M7.6M7.17M6.5M6.25M2.8M3.88M4.17M4.56M2.68M1.58M1.24M1.05M1.16M1.15M1.28M
Interest Expense23.85M22.5M21.69M24.38M21.64M21.65M14.65M5.09M7.24M5.37M5.26M5.16M5.06M2.85M000000
Other Income/Expense3.69M-12.54M-7.99M-13.54M-11.59M-13.7M-10.6M2.16M-805K-2.14M-660K-680K-489K340K1.67M863K2.81M449K1.51M1.94M
Pretax Income-137.56M28.27M36.12M-179.09M369.62M-175.12M-172.8M-173.98M-127M-138.69M-108.99M-103.38M47.68M-41.79M-82.16M-72.05M44.37M-62.87M-63.37M-29.92M
Pretax Margin %-186.56%10.71%14.08%-644.97%68.11%-7004.6%----3905.63%-677.08%-653.29%32.6%-66.82%-260.2%-222.28%29.23%-229.13%-165.54%-65.21%
Income Tax7K29K20M-437K1.75M103K546K00-3.31M2.02M742K017K3.79M0002K0
Effective Tax Rate %-0.01%0.1%55.37%0.24%0.47%-0.06%-0.32%0%0%2.39%-1.86%-0.72%0%-0.04%-4.61%0%0%0%-0%0%
Net Income-132.73M30.81M-23.75M-175.24M370.44M-173.09M-170.54M-170.79M-125.3M-132.86M-109.68M-102.95M48.67M-41.33M-85.51M-72.05M44.37M-62.87M-63.37M-29.92M
Net Margin %-180.01%11.67%-9.26%-631.11%68.26%-6923.4%----3741.59%-681.36%-650.53%33.28%-66.07%-270.82%-222.28%29.23%-229.13%-165.54%-65.21%
Net Income Growth %-135.83%117.8%86.07%-2.6%395.65%-30.27%-55.49%-65.91%-357.42%-221.51%-28.26%-42.89%9.71%34.27%-34.93%-140.76%265.43%-203.26%-30.85%-119.85%
Net Income (Continuing)-137.57M28.24M16.12M-178.65M367.86M-175.22M-173.34M-173.98M-127M-135.38M-111.02M-104.13M47.68M-41.81M-85.94M-72.05M44.37M-62.87M-63.37M-29.92M
Discontinued Operations00000000000000000000
Minority Interest-15.06M-5.72M37.36M-2.51M904K3.49M5.62M8.43M11.61M13.31M15.82M17.16M18.33M19.33M19.82M20.25M0000
EPS (Diluted)-0.930.22-0.17-1.262.75-1.39-1.40-1.38-1.02-1.24-1.02-0.960.45-0.39-0.81-0.670.41-0.60-0.61-0.29
EPS Growth %-133.82%115.83%87.86%8.7%369.61%-12.1%-37.25%-43.75%-326.67%-217.95%-25.93%-43.28%9.76%35%-32.79%-131.03%257.69%-200%-29.79%-123.08%
EPS (Basic)-0.930.22-0.17-1.262.78-1.39-1.40-1.38-1.02-1.24-1.02-0.960.46-0.39-0.81-0.670.42-0.60-0.61-0.29
Diluted Shares Outstanding142.42M140.71M135.7M139.04M134.48M124.85M121.99M124.2M123.28M107.42M107.31M107M108.14M106.04M105.75M105.75M107.93M104.53M104.53M104.1M
Basic Shares Outstanding142.42M140.05M135.7M139.04M133.36M124.85M121.99M124.2M123.28M107.42M107.31M107M106.76M106.04M105.75M105.75M105.55M104.53M104.27M103.19M
Dividend Payout Ratio--------------------